GRCE
NASDAQ · Pharmaceuticals
Grace Therapeutics Inc
$2.12
-0.06 (-2.75%)
Open$2.22
Previous Close$2.18
Day High$2.23
Day Low$2.08
52W High$5.18
52W Low$1.79
Volume—
Avg Volume360.2K
Market Cap34.50M
P/E Ratio—
EPS$-0.48
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+989.2% upside
Current
$2.12
$2.12
Target
$23.09
$23.09
$18.68
$23.09 avg
$33.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.56M | 18.44M | 15.17M |
| Net Income | 2.85M | 2.16M | 2.15M |
| Profit Margin | 14.6% | 11.7% | 14.2% |
| EBITDA | 5.50M | 5.11M | 4.77M |
| Free Cash Flow | 2.45M | 3.17M | 1.86M |
| Rev Growth | +16.3% | +19.0% | +18.1% |
| Debt/Equity | 0.50 | 0.57 | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |